share_log

樂普生物-B:自願性公告 MRG003用於治療復發性 / 轉移性鼻咽癌(R/M NPC)獲FDA授予快速通道資格

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG003 FOR THE TREATMENT OF R/M NPC

Hong Kong Stock Exchange ·  Dec 3, 2023 19:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more